Evolus (EOLS) Total Non-Current Liabilities (2017 - 2022)

Evolus (EOLS) posted Total Non-Current Liabilities of $159.5 million for Q4 2022, down 2.46% on a QoQ basis from $163.5 million in Q3 2022, and up 21.87% year-over-year from $130.9 million in Q4 2021.

Evolus (EOLS) Total Non-Current Liabilities (2017 - 2022) Analysis & Trends

Evolus' Total Non-Current Liabilities history runs 6 years deep, the most recent figure standing at $159.5 million for Q4 2022.

  • Quarterly Total Non-Current Liabilities rose 21.87% year-over-year to $159.5 million in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $159.5 million (up 21.87% YoY) and the FY2022 annual result came in at $159.5 million, up 21.87% from the prior year.
  • Total Non-Current Liabilities was $159.5 million for Q4 2022 at Evolus, down from $163.5 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $240.5 million in Q4 2020 and bottomed at $34.8 million in Q1 2018.
  • A 5-year average of $116.2 million and a median of $117.3 million in 2020 frame the typical range for Total Non-Current Liabilities.
  • Annual changes were most pronounced in 2018 — Total Non-Current Liabilities sank 83.64% — and 2019, when it jumped 225.1%.
  • Evolus' Total Non-Current Liabilities stood at $37.3 million in 2018, then jumped by 212.14% to $116.3 million in 2019, then surged by 106.77% to $240.5 million in 2020, then tumbled by 45.58% to $130.9 million in 2021, then climbed by 21.87% to $159.5 million in 2022.
  • Business Quant data shows EOLS's Total Non-Current Liabilities at $159.5 million in Q4 2022, $163.5 million in Q3 2022, and $164.1 million in Q2 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 14.92 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 18.28 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 11.64 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 33.47 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 599.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 20.09 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 1.24 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 6.26 Bn
10 Evolus 390.47 Mn 340.68 Mn 48.90 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2022 159.48 Mn
Sep 30, 2022 163.50 Mn
Jun 30, 2022 164.06 Mn
Mar 31, 2022 153.41 Mn
Dec 31, 2021 130.87 Mn
Sep 30, 2021 112.82 Mn
Jun 30, 2021 128.73 Mn
Mar 31, 2021 128.91 Mn
Dec 31, 2020 240.48 Mn
Mar 31, 2020 117.33 Mn
Dec 31, 2019 116.30 Mn
Jun 30, 2019 114.43 Mn
Mar 31, 2019 99.67 Mn
Dec 31, 2018 37.26 Mn
Sep 30, 2018 37.31 Mn
Jun 30, 2018 35.20 Mn
Mar 31, 2018 34.81 Mn
Dec 31, 2017 227.78 Mn